ArticleClinical parkinsonism & related disorders2025
Advance care planning in Hispanic populations with Parkinson's Disease: Investigating disparities in end-of life care.
Article in Clinical parkinsonism & related disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Patient autonomy in advance care planning for Parkinson's disease: Systematic review with narrative synthesis.Palliative & supportive care · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Introduction: Advance care planning (ACP) is a tool for optimizing end-of-life care and is an important aspect of healthcare for people with Parkinson's disease (PD). However, there may be disparities in access to ACP based on race and/or ethnicity. Methods: We conducted a cross-sectional survey of people with PD and care partners from a diverse academic Movement Disorders clinic regarding familiarity with ACP and sociodemographic factors. We compared prior experiences with ACP, with a primary outcome examining prior completion of healthcare power of attorney (HPOA) and advance directives (AD) among Hispanics and non-Hispanics in the cohort. Univariate analysis was utilized to compare cohort demographics. A multinomial logistic regression was performed to control for possible confounders. Results: 250 participants completed the survey, including 116 (46.4 %) who self-identified as Hispanic and 127 (50.8 %) non-Hispanic. Only 20 % of Hispanic participants had previously completed HPOA documentation versus 66.9 % non-Hispanics (p < 0.001). The rates of completion for AD were 6.1 % and 31.7 %, respectively (p < 0.001). Hispanic respondents were less likely to have heard about these documents and more likely to wait until later in the disease course to discuss ACP, despite a majority viewing these discussions as important. These trends remained when controlling for several demographic variables; however, age and preferred language of survey emerged as potential confounders for some answer choices. Conclusions: Hispanic people with PD may be less likely to utilize ACP than their non-Hispanic counterparts. Awareness of these resources or cultural factors may play a role and should be explored further in future studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.